In recent years, the demand for cognitive enhancers has surged globally, with South Africa emerging as a significant market for such substances. Among these, modafinil, a medication originally developed for the treatment of narcolepsy and other sleep disorders, has gained popularity as a nootropic—a substance that purportedly improves cognitive function, particularly executive functions, memory, creativity, or motivation, in healthy individuals. This article explores the implications of buying modafinil in South Africa, including its legality, potential benefits, risks, and the growing trend of self-medication.